InDex Pharmaceuticals Holding AB (publ) announces changes in the Nomination Committee for the 2021 Annual General Meeting
March 15, 2021 – InDex Pharmaceuticals Holding AB (publ) today announced changes in the composition of the Nomination Committee for the 2021 Annual General Meeting due to changes in the ownership structure of the company.Changes in the ownership structure of InDex Pharmaceuticals Holding AB (publ) in connection with the rights issue in February 2021 has led to changes in the composition of the Nomination Committee for the 2021 Annual General Meeting. Following the changes, the Nomination Committee for the 2021 Annual General Meeting of InDex Pharmaceuticals Holding AB (publ) consists of: